Bioenergetic Profiling in Glioblastoma Multiforme Patients with Different Clinical Outcomes.

ABSTRACT: The accumulation of cell biomass is associated with dramatically increased bioenergetic and biosynthetic demand. Metabolic reprogramming, once thought as an epiphenomenon, currently relates to disease progression, also in response to extracellular fate-decisive signals. Glioblastoma multiforme patients often suffer misdiagnosis, short survival time, low quality of life, and poor disease management options. Today, tumor genetic testing and histological analysis guide diagnosis and treatment. We and others appreciate that metabolites complement translational biomarkers and molecular signatures in disease profiling and phenotyping. Herein, we coupled a mixed-methods content analysis to a mass spectrometry-based untargeted metabolomic analysis on plasma samples from glioblastoma multiforme pat

SUBMITTER: Bafiti V 

PROVIDER: S-EPMC10051505 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature